RT Journal Article
SR Electronic
T1 Performance evaluation of a multinational data platform for critical care in Asia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.10.21260243
DO 10.1101/2021.07.10.21260243
A1 Luigi Pisani
A1 Thalha Rashan
A1 Maryam Shamal
A1 Aniruddha Ghose
A1 Bharath Kumar Tirupakuzhi Vijayaraghavan
A1 Swagata Tripathy
A1 Diptesh Aryal
A1 Madiha Hashmi
A1 Basri Nor
A1 Yen Lam Minh
A1 Arjen M. Dondorp
A1 Rashan Haniffa
A1 Abi Beane
YR 2021
UL http://medrxiv.org/content/early/2021/07/14/2021.07.10.21260243.abstract
AB Objective We aimed to evaluate the quality of a multinational intensive care unit (ICU) network of registries of critically ill patients established in seven Asian low and middle income countries (LMICs).Methods The Critical Care Asia federated registry platform enables ICUs to collect clinical, outcome and process data for aggregate and unit-level analysis. The evaluation used the standardised criteria of the Directory of Clinical Databases (DoCDat) and a framework for data quality assurance in medical registries. Six reviewers assessed structure, coverage, reliability and validity of the ICU registry data. Case mix and process measures on patient episodes from June to December 2020 were analysed.Results Data on 20,507 consecutive patient episodes from 97 ICUs in Afghanistan, Bangladesh, India, Malaysia, Nepal, Pakistan and Vietnam were included. The quality level achieved according to the ten prespecified DoCDat criteria was high (average score 3.4 out of 4) as was the structural and organizational performance -- comparable to ICU registries in high-income countries. Identified strengths were types of variables included, reliability of coding, data completeness and validation. Potential improvements include extension of national coverage.Conclusion The Critical Care Asia platform evaluates well using standardised frameworks for data quality and equally to registries in resource-rich settings.Funding This work was undertaken as part of the existing Wellcome Innovations Flagship award, Collaboration for Research, Improvement and Training in Critical CARE in ASIA (ref. 215522/Z/19/Z). The funder had no role in the decision to publish or in the preparation of this manuscript.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding This work was undertaken as part of the existing Wellcome Innovations Flagship award, Collaboration for Research, Improvement and Training in Critical CARE in ASIA (ref. 215522/Z/19/Z). The funder had no role in the decision to publish or in the preparation of this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Oxford Tropical Research Ethical Committee (OxTREC) exemption from ethical review on 16 June 2020All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData on which the scoring was performed is available upon request to CCA coordination and acceptance by individual National Registries.